#1013 Альфа-оценка 20.6

BarbarianCap

Аналитик Twitter
@BarbarianCap · отслеживается с фев 2026
1013
BUZZBERG Лидерборд ранжируется по Alpha Score, который учитывает среднюю доходность спикера, число его коллов и репутацию — рейтинг авторитетности источника, который может только повысить скор, но не понизить. Читать FAQ
Альфа-оценка 20.6
Сигналы
29
Винрейт
53.6%
доходность
-1.6%
Сигналы 29 4852 Постов отслежено · 23.7/день Постил сегодня
Сигналы
0
30д 7
90д 9
Лучшие сигналы
USO Лонг +35.3%
CROX Лонг +20.1%
XLE Лонг +19.3%
Худшие сигналы
BZFD Шорт -71.6%
ESLOF Лонг -41.7%
GLD Лонг -17.9%
Самые упоминаемые
GOLD ×2
CROX ×2
XLE ×2
Последние сигналы
PGNY Лонг 3 недели назад
HKMPY Лонг 3 недели назад
SDZNY Лонг 3 недели назад
Винрейт 54% Лонг 26 Шорт 3
Винрейт
59%
30д 50%
90д 63%
Средняя доходность -1.6% Доходность лонгов +1.3% Доходность шортов -26.0%
Средняя доходность
+1.2%
30д +0.9%
90д -4.3%
Загрузка графиков...
Результат
Результат
Сортировка
Тема Позиция
Тикер
Сторона
Упоминания
Первый колл
Цена колла
P&L
Тезис
Тема
Источник
Лонг
01 мар
$483.75
-17.9%
The author suggests gold is poised for a significant price increase, as even a marginal 1 basis point rise in currently tiny allocations would result in a 1.5% price appreciation.
The author suggests gold is poised for a significant price increase, as even a marginal 1 basis point rise in currently tiny allocations would result in a 1.5% price appreciation.
Сырьё
Лонг
14 фев
$54.35
+19.3%
The author reiterates a long-held thesis that the failure of the EV/ESG narrative will be a long-term tailwind for the traditional energy sector.
The author reiterates a long-held thesis that the failure of the EV/ESG narrative will be a long-term tailwind for the traditional energy sector.
Тематические ETF
Лонг
14 фев
$224.23
-16.1%
The consulting sector is poised for growth driven by increasing corporate demand for generative AI implementation, as evidenced by Capgemini's forward-looking guidance.
The consulting sector is poised for growth driven by increasing corporate demand for generative AI implementation, as evidenced by Capgemini's forward-looking guidance.
ПО для ИИ
Лонг
12 фев
$96.20
+20.1%
The author believes the pre-market price action signals a bottom and a trend reversal, suggesting the stock is poised to move higher.
The author believes the pre-market price action signals a bottom and a trend reversal, suggesting the stock is poised to move higher.
Ритейл и мобильность
Лонг
09 авг
$245.89
+5.6%
Lupron demand seen lifted by fertility spotlight
Buy ABBV as Lupron, used in fertility protocols, stands to benefit from increased public attention on fertility treatments driven by AOC's egg-freezing news; very thin catalyst.
Фарма и биотех
Лонг
09 авг
$46.21
-6.0%
Generic fertility drug makers seen as beneficiaries
Buy generic drug makers TEVA, Sandoz (SDZNY), and Hikma (HKMPY) as fertility drug generics see potential demand uplift from increased public awareness around egg freezing; speculative thematic call.
Фарма и биотех
Лонг
09 авг
$33.38
-3.1%
Gonal-f demand seen rising on fertility awareness
Buy Merck KGaA (MKKGY) as its Gonal-f fertility drug benefits from heightened public awareness around egg freezing following AOC's announcement; thin catalyst but author flags it as a positive.
Банки
Лонг
09 авг
$13.60
+0.1%
AOC egg news boosts OGN Follistim demand
Buy OGN as AOC's public egg-freezing announcement raises fertility treatment visibility; Follistim is a key fertility drug and OGN is in acquisition process, giving a near-term catalyst overlay.
Фарма и биотех
Лонг
09 авг
$28.20
-9.0%
PGNY fertility benefits demand seen rising
Buy PGNY as the leading fertility benefits platform; AOC's public egg-freezing announcement may accelerate employer and employee interest in fertility benefit coverage, directly benefiting PGNY's core business.
Медицинские услуги
Лонг
09 авг
$89.95
-5.8%
Generic fertility drug makers seen as beneficiaries
Buy generic drug makers TEVA, Sandoz (SDZNY), and Hikma (HKMPY) as fertility drug generics see potential demand uplift from increased public awareness around egg freezing; speculative thematic call.
Фарма и биотех
Лонг
09 авг
$35.34
+2.4%
Generic fertility drug makers seen as beneficiaries
Buy generic drug makers TEVA, Sandoz (SDZNY), and Hikma (HKMPY) as fertility drug generics see potential demand uplift from increased public awareness around egg freezing; speculative thematic call.
Фарма и биотех
Лонг
31 июл
$42.53
-6.1%
Buy Brookfield Asset Management given its direct ownership of Westinghouse Electric, whose confidential IPO filing is a value-unlocking catalyst that could surface significant embedded value in BN's portfolio.
Buy Brookfield Asset Management given its direct ownership of Westinghouse Electric, whose confidential IPO filing is a value-unlocking catalyst that could surface significant embedded value in BN's portfolio.
Рынки капитала
Лонг
31 июл
$86.00
+12.0%
Buy Cameco as a direct uranium/nuclear fuel beneficiary of the nuclear renaissance theme, with the Westinghouse IPO filing serving as a concrete catalyst validating renewed institutional interest in nuclear power infrastructure.
Buy Cameco as a direct uranium/nuclear fuel beneficiary of the nuclear renaissance theme, with the Westinghouse IPO filing serving as a concrete catalyst validating renewed institutional interest in nuclear power infrastructure.
Критические минералы
Лонг
12 мая
$21.88
+14.2%
Structural phosphate supply deficit drives fertilizer prices higher, benefiting Mosaic as a key producer with reduced spending and guidance withdrawal.
Structural phosphate supply deficit drives fertilizer prices higher, benefiting Mosaic as a key producer with reduced spending and guidance withdrawal.
Химпром
Лонг
07 апр
$132.48
+18.3%
Neurocrine's acquisition of Soleno adds a promising late-stage asset, providing strategic long-term growth for NBIX.
Neurocrine's acquisition of Soleno adds a promising late-stage asset, providing strategic long-term growth for NBIX.
Фарма и биотех
Показано 15 из 29 коллов · сортировка по упоминаниям

У BarbarianCap на Buzzberg отслеживается 29 торговых идей по 29 тикерам с февраля 2026. винрейт 54% по 28 оцененным сигналам, средняя доходность -1.6%. #1013 в рейтинге Buzzberg Alpha. Чаще всего покрывает: GOLD, CROX, XLE.